Europa Biosite is delighted to announce the partnership of LubioScience and BPS Bioscience to distribute their portfolio in Switzerland. This additional partnership extends the relationship between BPS Bioscience and Europa Biosite and its subsidiaries to 13 countries with distribution in Austria, Germany, Ireland, Nordics and Baltics, Switzerland and the United Kingdom.
BPS Bioscience’s mission is to advance new scientific discoveries that lead to therapies, by creating innovative solutions for research. With a focus on immunotherapy, epigenetics, coronavirus, CRISPR, and cell signalling, their portfolio includes over 4000 high quality recombinant cell lines, lentiviruses and proteins, as well as biochemical and cell-based screening services.
If you are interested in developing a partnership with any of the Europa Biosite subsidiaries, please do get in touch.
Partner with Europa Biosite
Europa Biosite partners with life science suppliers who share our values on quality, innovation and service.
If you are looking for a leading European distributor partner, we want to hear from you.